For sciatica patients, the genetically engineered pain medicine etanercept is no better at treating leg and lower back pain than traditional steroid injections, according to a new study.
Johnson & Johnson (NYSE: JNJ), the world's second-biggest health care company, is expected to report higher first-quarter profit as strong performance of new drugs offsets drags from generic competition and strings of recalls.
A federal appellate court ruled on Tuesday that drugmaker Pfizer can face asbestos liability suits in state court over products once manufactured by a bankrupt subsidiary, dragging out a dispute that has already lasted more than 30 years.
A federal appellate court ruled on Tuesday that drugmaker Pfizer can face asbestos liability suits in state court over products once manufactured by a bankrupt subsidiary, dragging out a dispute that has already lasted more than 30 years.
U.S. regulators gave the nod to an imaging test from Eli Lilly and Co. that can for the first time help doctors detect brain plaque tied to Alzheimer's disease, the company said.
Johnson & Johnson's blood clot preventer Xarelto proved as effective as and safer than standard treatments against blood clots of the lung in a big study, possibly paving the way for it to become the eventual preferred treatment for the third most common cause of deaths in hospitals.
Apple's push for a tax holiday on overseas profits is unlikely to influence the Obama administration's position on the issue, a White House source told Talking Points Memo.
Many patients taking a widely prescribed class of oral cancer drugs are also using a variety of medications that could reduce the effectiveness of the cancer treatment or increase its toxic side effects, according to research by Medco Health Solutions Inc.
Pfizer, the world's largest drug maker, is scheduled to appear in court in May over Celebrex, a drug Bingham Young University and researcher Dr. Daniel Simmons claim royalties that could amount to millions to a billion dollars.
Europe is undermining drug innovation by cutting prices, raising barriers to new medicines and freeloading off others in Asia and the United States who are more willing to pay, the boss of Pfizer, the world's largest drugmaker, said.
Pfizer Inc
is more likely to spin off its animal health unit than sell it outright, reflecting the expected investor appeal of such a large standalone business, its chief executive said on Monday.
On Monday, March 12, Pfizer Inc., Johnson & Johnson and Regeneron Pharmaceuticals will argue that they should continue to study the drug, while taking the necessary safety precautions to protect their patients. Two years ago a series experiments to develop a new prescription drug that would successfully alleviate the pain caused by arthritis conducted by some of the world’s biggest pharmaceutical companies were put on hold by the United States’ Food and Drug Administration (FDA).
The Food and Drug Administration rejected an experimental combination cholesterol drug produced by Merck & Co Monday. The experimental drug, known as MK-0653C, hopes to fight heart disease in two different ways, by combining Lipitor and Zetia.
Occupy Wall Street drew a top U.S. security agency's scrutiny, Rolling Stone reported, as protesters across the country tried to revive the movement in a day of action against corporate greed.
Occupy Wall Street roared back to life on Wednesday as ten protesters were arrested in a day of resurgent OWS rallies.
U.S. health regulators will add warnings to the labels of widely used cholesterol lowering drugs, such as Lipitor, saying they may raise levels of blood sugar and could cause memory loss.
Pharmaceutical company Glenmark Generics issued a recall on Friday for birth control pills norgestimate and ethinyl estradiol tablets due to a packaging error that poses a risk for consumers to become pregnant, just months after a major recall from another drug company.
Seven lots of birth control pills were recalled by Glenmark Generics after a packaging error that could leave the pills ineffective was discovered.
Romney's views on contraception oscillate to fit his political agenda.
It was a rare case where a megalith drug company's error could lead to a truly jarring side effect: pregnancy. Which begs the question: Could Pfizer realistically pay damages as the result of an unexpected pregnancy caused by a recall? Could a suit feasibly force the company to cover the cost of an abortion?
As word spread about the birth control recall of at least one million pill packets in the U.S. from Pfizer on Tuesday, panic ensued amongst women nationwide about their risk of becoming pregnant. But how do you know if the birth control pills you are taking are part of the recall?
Drugmakers Pfizer Inc. (NYSE:PFE) and Eli Lilly & Co. (NYSE:LLY) have seen profits squeezed as lucrative blockbuster drugs came off patent and face competition from low-cost generic drugs. Merck & Co. Inc. (NYSE:MRK) is set to feel the hit in the second half of 2012.